POLISCOPE
Back to feed

The civic record

Read. Follow. Verify.
High Impact

Congressional Hearing on Opioid Treatment Access

Original title: MEDICAL EXPERTS: INADEQUATE FEDERAL APPROACH TO OPIOID TREATMENT AND THE NEED TO EXPAND CARE

Record date · January 1, 2019

Track this bill to get notified when it advances a stage. One tap to stop, anytime.

What This Bill Does

The House Committee on Oversight and Reform held a hearing on June 19, 2019, to examine federal shortcomings in opioid addiction treatment and discuss potential legislation to expand access to care. Medical experts and practitioners testified on the barriers preventing individuals with s from receiving .

Why it matters

This hearing serves as a formal legislative review of federal opioid policies, which directly influences future funding and regulatory changes for addiction treatment services nationwide.

Who It Affects

Groups the bill's text affects, as described in the record. Being affected is not a position for or against it.

Directly affected

Individuals with substance use disorders

The hearing focuses on potential legislative changes that could alter their access to evidence-based treatment services.

Directly affected

Medical and nursing professionals

These professionals provide the testimony that informs federal policy regarding the standards and availability of addiction treatment.

Key Facts

  • The hearing was held on June 19, 2019, to address the 'inadequate federal approach' to opioid treatment.
  • Between 2013 and 2017, more than 270,000 Americans died from drug overdoses.
  • Data from the National Survey on Drug Use and Health indicates that only 10.8% of individuals with substance use disorders receive specialty treatment.
  • The committee reviewed testimony from six medical and nursing experts regarding barriers to care.
Show all 5 facts
  • The hearing included the submission of external reports, including a New Yorker article on the pain pill epidemic and statements from SMART Recovery and Faces and Voices of Recovery.

Frequently Asked Questions

What was the purpose of this hearing?
The committee met to discuss why current federal approaches to opioid treatment are insufficient and to explore potential legislation to increase access to care for those with s.
Who testified at the hearing?
The witnesses included representatives from the American Medical Association, the American Society of Addiction Medicine, the American Psychological Association, National Nurses United, the Berkeley-Morgan County Board of Health, and Children and Family Futures.

What else do you want to know?

News Coverage

No news coverage found yet. Articles are indexed twice daily.

Full breakdown

Who this bill affects and the strongest case for and against it, written only from the bill’s own text.

Discoveries

1 pattern noticed across the record

Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.

policy shift90% confidence

Focus on Treatment Access

The hearing highlights a shift in congressional focus from purely enforcement-based opioid strategies toward expanding medical treatment access.

Connected Entities

Angela Gray, Committee on Oversight and Reform, Elijah E. Cummings and 5 more
PersonAngela Gray“Nurse Director at Berkeley-Morgan County Board of Health”Map →
OrganizationCommittee on Oversight and Reform“House of Representatives committee conducting the hearing”Map →
PersonElijah E. Cummings“Chairman of the Committee on Oversight and Reform”Map →
PersonSusan R. Bailey“President-elect of the American Medical Association”Map →
PersonJean Ross“President of National Nurses United”Map →
PersonArthur C. Evans“CEO of the American Psychological Association”Map →
PersonYngvild K. Olsen“Vice President of the American Society of Addiction Medicine”Map →
PersonNancy K. Young“Executive Director of Children and Family Futures”Map →

Sources

Open source document

www.govinfo.gov

Analysis Score

0–100
  • Significance80
    How much this matters to a regular citizen
  • Controversy40
    Intensity of disagreement among stakeholders
  • Entertainment10
    Compellingness for a non-policy-wonk reader
  • Buzz20
    Current news / social attention level

Publisher tools

Share or embed this record

POLISCOPE publisher tools

Share or embed this record